Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SEPT5 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
mRNA | MALT1 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
mRNA | PRR4 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
mRNA | ZMYM4 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
mRNA | CLCN5 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
mRNA | COL9A3 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
mRNA | FSTL1 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.01 |
mRNA | SLC5A9 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
mRNA | POPDC3 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
mRNA | GSX1 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |